Multimorbidity challenge: Prevalence and structure of multiple chronic conditions in Lithuanian population
3rd Indo-Global Summit & Expo on Healthcare
October 05-07, 2015 New Delhi, India

Rokas Navickas

Vilnius University, Lithuania

Posters-Accepted Abstracts: Health Care: Current Reviews

Abstract:

Multimorbidity, defined as the coexistence of two or more chronic conditions in the same person at the point in time by increasing overall mortality and requiring significant financial and human resources is a rising threat to the world�??s healthcare systems. Everyday medical practice based on clinical guidelines traditionally concentrates on a single chronic disease which might not be the best practice when applied to patients with multimorbidity. Knowledge of prevalence and patterns of multimorbidity, stratified not only by age and gender, is vital to provide high-quality healthcare adapted to patients�?? needs. Analysing single national database covering the period of 2.5 years and reflecting >95% of overall national healthcare costs 452,769 subjects were included. The prevalence of chronic diseases being 17.2%, 94.6% of the chronically diseased subjects had >1 chronic condition, most frequent being hypertension in over 85% of patients followed by ischemic heart disease. The number of chronic diseases increased with the age especially after 45 years and female gender (p<0.001). Outpatient and primary care visits per 1000 population were 2.1 times more frequent and home visits were 9.6 times more prevalent in a multimorbid compared to a single diseased group. Multimorbidity accounted for 61% probability of 30-day readmission rate and 258,761 additional bed days per year. Tendency of more frequent hospitalization was observed in the ages of 18-24 and 25-34 years. Multimorbidity and its increasing prevalence among the younger patients will put additional strain on primary as well as secondary healthcare at an earlier stage. Multimorbidity has a high care demand and an obvious need for a multidisciplinary team approach, so stratification of the general population, targeting high-risk patients and developing personalized and cost-efficient care plans seems inevitable.

Biography :

Email: Rokas.Navickas@santa.lt